Deposition of Bacillus anthracis endospores within either the lungs or nasal passages of A/J mice after aerosol exposure was influenced by different particle sized aerosols and resulted in different infection kinetics. The infection resulting from the inhalation of endospores within a 12 μm particle aerosol was prolonged compared to that from a 1 μm particle aerosol with a mean time-to-death of 161±16.1 h and 101.6±10.4 h, respectively. Inhalation of endospores within 1 μm or 12 μm particle aerosols resulted in a median lethal dose of 2432 and 7656 c.f.u., respectively. Initial involvement of the upper respiratory tract lymph nodes was observed in 75–83 % of mice exposed to either the 1 μm or 12 μm particle inhalational infections. Lung deposition was significantly greater after inhalation of the 1 μm particle aerosol with pronounced involvement of the mediastinal lymph node. Gastrointestinal involvement was observed only in mice exposed to 12 μm particle aerosols where bacteriological and histopathological analysis indicated primary gastritis (17 %), activation of the Peyer's patches (72 %) and colonization and necrosis of the mesenteric lymph nodes (67 %). Terminal disease was characterized by bacteraemia in both inhalational infections with preferential dissemination to spleen, liver, kidneys and thymus. Immunization with 1 μg recombinant protective antigen vaccine was equally efficacious against B. anthracis infections arising from the inhalation of 1 and 12 μm particle aerosols, providing 73–80 % survival under a suboptimum immunization schedule.
BeattyM. E.,
AshfordD. A.,
GriffinP. M.,
TauxeR. V.,
SobelJ.2003; Gastrointestinal anthrax: review of the literature. Arch Intern Med 163:2527–2531[CrossRef]
DruettH. A.,
HendersonD. W.,
PackmanL. P.,
PeacockS.1953; Studies on respiratory infection. I. The influence of particle size on respiratory infection with anthrax spores. J Hyg (Lond 51:359–371[CrossRef]
DruettH. A.,
RobinsonJ. M.,
HendersonD. W.,
PackmanL.,
PeacockS.1956a; The influence of aerosol particle size on infection of the guinea-pig with Pasteurella pestis
. J Hyg (Lond) 54:37–48[CrossRef]
DrysdaleM.,
HeningerS.,
HuttJ.,
ChenY.,
LyonsC. R.,
KoehlerT. M.2005; Capsule synthesis by Bacillus anthracis is required for dissemination in murine inhalation anthrax. EMBO J 24:221–227[CrossRef]
DucL. H.,
HongH. A.,
CuttingS. M.2003b; Germination of the spore in the gastrointestinal tract provides a novel route for heterologous antigen delivery. Vaccine 21:4215–4224[CrossRef]
DuncanS.,
HoJ.2008; Estimation of viable spores in Bacillus atrophaeus (BG) particles of 1 to 9 μm size range. Clean Soil Air Water 36:584–592[CrossRef]
DuncanE. J. S.,
KournikakisB.,
HoJ.,
HillI.2009; Pulmonary deposition of aerosolized Bacillus atrophaeus in a swine model due to exposure from a simulated anthrax letter incident. Inhal Toxicol 21:141–152[CrossRef]
Flick-SmithH. C.,
WatersE. L.,
WalkerN. J.,
MillerJ.,
StaggA. J.,
GreenE. D.,
WilliamsonE. D.2005; Mouse model characterisation for anthrax vaccine development: comparison of one inbred and one outbred mouse strain. Microb Pathog 38:33–40[CrossRef]
FrankelA. E.,
KuoS. R.,
DostalD.,
WatsonL.,
DuesberyN. S.,
ChengC. P.,
ChengH. J.,
LepplaS. H.2009; Pathophysiology of anthrax. Front Biosci 14:4516–4524
FujimuraY.,
TakedaM.,
IkaiH.,
HarumaK.,
AkisadaT.,
HaradaT.,
SakaiT.,
OhuchiM.2004; The role of M cells of human nasopharyngeal lymphoid tissue in influenza virus sampling. Virchows Arch 444:36–42[CrossRef]
GlomskiI. J.,
DumetzF.,
JouvionG.,
HuerreM. R.,
MockM.,
GoossensP. L.2008; Inhaled non-capsulated Bacillus anthracis in A/J mice: nasopharynx and alveolar space as dual portals of entry, delayed dissemination, and specific organ targeting. Microbes Infect 10:1398–1404[CrossRef]
GueirardP.,
AveP.,
BalazucA.-M.,
ThibergeS.,
HuerreM.,
MilonG.,
GuisoN.2003; Bordetella bronchiseptica persists in the nasal cavities of mice and triggers early delivery of dendritic cells in the lymph nodes draining the lower and upper respiratory tract. Infect Immun 71:4137–4143[CrossRef]
HoltyJ.-E. C.,
BravatD. M.,
LiuH.,
OlshenR. A.,
McDonaldK. M.,
OwensD. K.2006a; Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med 144:270–280[CrossRef]
KangT. J.,
LeeG. S.,
KimS. K.,
JinS. H.,
ChaeG. T.2010; Comparison of two mice strains, A/J and C57BL/6, in caspase-1 activity and IL-1 β secretion of macrophage to Mycobacterium leprae infection. Mediators Inflamm (in press
KwaS.-F.,
BeverleyP.,
SmithA. L.2006; Peyer's patches are required for the induction of rapid Th1 responses in the gut and mesenteric lymph nodes during an enteric infection. J Immunol 176:7533–7541[CrossRef]
LovingC. L.,
KhuranaT.,
OsorioM.,
LeeG. M.,
KellyV. K.,
StibitzS.,
MerkelT. J.2009; Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model. Infect Immun 77:255–265[CrossRef]
NicholsonW. L.,
Farjado-CavazosP.,
RebeilR.,
SliemanT. A.,
ReisenmanP. J.,
LawJ. F.,
XueY.2002; Bacterial endospores and their significance in stress resistance. Antonie van Leeuwenhoek 81:27–32[CrossRef]
ParkH.-S.,
FrancisK. P.,
YuJ.,
ClearyP. P.2003; Membranous cells in nasal-associated lymphoid tissue: a portal of entry for the respiratory mucosal pathogen group A streptococcus. J Immunol 171:2532–2537[CrossRef]
PassalacquaK. D.,
BergmanN. H.2006; Bacillus anthracis : interactions with the host and establishment of inhalational anthrax. Future Microbiol 1:397–415[CrossRef]
RedmondC.,
BaillieL. W. J.,
HibbsS.,
MoirA. J. G.,
MoirA.2004; Identification of proteins in the exosporium of Bacillus anthracis
. Microbiology 150:355–363[CrossRef]
RoyC. J.,
HaleM.,
HartingsJ. M.,
PittL.,
DunihoS.2003; Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in Balb/c mice. Inhal Toxicol 15:619–638[CrossRef]
SanzP.,
TeelL. D.,
AlemF.,
CarvalhoH. M.,
DarnellS. C.,
O'BrienA. D.2008; Detection of Bacillus anthracis spore germination in vivo by bioluminescence imaging. Infect Immun 76:1036–1047[CrossRef]
StokesM. G. M.,
TitballR. W.,
NeesonB. N.,
GalenJ. E.,
WalkerN. J.,
StaggA. J.,
JennerD. C.,
ThwaiteJ. E.,
NataroJ. P.other authors2007; Oral administration of a Salmonella enterica -based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis
. Infect Immun 75:1827–1834[CrossRef]
TamM. A.,
RydströmA.,
SundquistM.,
WickM. J.2008; Early cellular responses to Salmonella infection: dendritic cells, monocytes, and more. Immunol Rev 225:140–162[CrossRef]
ThomasR. J.,
WebberD.,
SellorsW.,
CollingeA.,
FrostA.,
StaggA. J.,
BaileyS. C.,
JayasekeraP. N.,
TaylorR. R.other authors2008; Characterisation and deposition of respirable large and small particle bioaerosols. Appl Environ Microbiol 74:6437–6443[CrossRef]
ThomasR. J.,
WebberD.,
CollingeA.,
StaggA. J.,
BaileyS. C.,
NunezA.,
GatesA.,
JayasekeraP. N.,
TaylorR. R.other authors2009; Different pathologies but equal levels of responsiveness to the recombinant F1 and V antigen vaccine and ciprofloxacin in a murine model of plague caused by small- and large-particle aerosols. Infect Immun 77:1315–1323[CrossRef]
ToddS. J.,
MoirA. J. G.,
JohnsonM. J.,
MoirA.2003; Genes of Bacillus cereus and Bacillus anthracis encoding proteins of the exosporium. J Bacteriol 185:3373–3378[CrossRef]
Van den BroeckW.,
DeroreA.,
SimeonsP.2006; Anatomy and nomenclature of murine lymph nodes: descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 312:12–19[CrossRef]
WilliamsonE. D.,
HodgsonI.,
WalkerN. J.,
ToppingA. W.,
DucharsM. G.,
MottJ. M.,
EstepJ.,
LeButtC.,
Flick-SmithH. C.other authors2005; Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax. Infect Immun 73:5978–5987[CrossRef]
ZauchaG. M.,
PittL. M.,
EstepJ.,
IvinsB. E.,
FriedlanderA. M.1998; The pathology of experimental anthrax in rabbits exposed by inhalation and subcutaneous inoculation. Arch Pathol Lab Med 122:982–992